Live Breaking News & Updates on Jonathan Aschoff

Stay updated with breaking news from Jonathan aschoff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

PBLA stock is a buy, Roth says

Following some good news for the company, Roth MKM analyst Jonathan Aschoff has maintained his “Buy” rating on Panbela Therapeutics. ....

Jenniferk Simpson , Jonathan Aschoff , Panbela Therapeutics , Panbela Therapeutics Stock Quote , Financials Nasdaq , Data Safety Monitoring Board ,